Total Payments
$182,083
2024 Payments
$88,999
Companies
29
Transactions
525
Medicare Patients
533
Medicare Billing
$75,865
Payment Breakdown by Category
Other$96,162 (52.8%)
Consulting$43,129 (23.7%)
Travel$26,245 (14.4%)
Food & Beverage$15,480 (8.5%)
Education$1,067 (0.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $95,737 | 34 | 52.6% |
| Consulting Fee | $43,129 | 15 | 23.7% |
| Travel and Lodging | $26,245 | 78 | 14.4% |
| Food and Beverage | $15,480 | 387 | 8.5% |
| Education | $1,067 | 9 | 0.6% |
| Grant | $400.00 | 1 | 0.2% |
| Honoraria | $25.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $66,775 | 104 | $0 (2024) |
| BioCryst US Sales Co., LLC | $48,101 | 89 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $23,110 | 86 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $18,482 | 66 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $12,941 | 11 | $0 (2024) |
| CSL Behring | $5,201 | 28 | $0 (2024) |
| Dermavant Sciences, Inc. | $2,009 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,274 | 34 | $0 (2024) |
| Allerderm Laboratories | $1,000 | 1 | $0 (2019) |
| GlaxoSmithKline, LLC. | $789.55 | 44 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $88,999 | 117 | GENZYME CORPORATION ($62,515) |
| 2023 | $40,182 | 77 | Takeda Pharmaceuticals U.S.A., Inc. ($19,795) |
| 2022 | $37,023 | 163 | BioCryst US Sales Co., LLC ($32,610) |
| 2021 | $12,135 | 124 | BioCryst US Sales Co., LLC ($9,834) |
| 2020 | $472.49 | 18 | Takeda Pharmaceuticals U.S.A., Inc. ($124.00) |
| 2019 | $1,504 | 10 | Allerderm Laboratories ($1,000) |
| 2018 | $915.17 | 7 | GENZYME CORPORATION ($513.98) |
| 2017 | $852.38 | 9 | GENZYME CORPORATION ($319.90) |
All Payment Transactions
525 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $115.96 | General |
| 11/15/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $6,929.00 | General |
| 11/15/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $797.28 | General |
| 11/15/2024 | GENZYME CORPORATION | — | Travel and Lodging | In-kind items and services | $303.97 | General |
| 11/15/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $298.26 | General |
| 11/15/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.15 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $62.15 | General |
| 11/06/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,066.00 | General |
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $994.43 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $742.33 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $269.00 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $218.79 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $185.00 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $10.00 | General |
| Category: Immunology | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $8.00 | General |
| Category: Immunology | ||||||
| 10/27/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $53.50 | General |
| Category: Immunology | ||||||
| 10/26/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $128.81 | General |
| Category: DERMATOLOGY | ||||||
| 10/26/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $71.26 | General |
| 10/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $41.84 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $123.92 | General |
| Category: Immunology | ||||||
| 10/24/2024 | BioCryst US Sales Co., LLC | ORLADEYO (Drug) | Food and Beverage | In-kind items and services | $61.37 | General |
| Category: Immunology | ||||||
| 10/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 5 | 151 | 1,881 | $34,528 | $23,093 |
| 2021 | 11 | 301 | 4,015 | $62,742 | $46,260 |
| 2020 | 3 | 81 | 510 | $8,745 | $6,512 |
Total Patients
533
Total Services
6,406
Medicare Billing
$75,865
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 95165 | Professional service for preparation and provision of 1 or more antigens | Office | 2022 | 40 | 1,040 | $18,019 | $13,087 | 72.6% |
| 95117 | Professional service for multiple injections of allergen | Office | 2022 | 61 | 784 | $9,827 | $6,227 | 63.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 23 | $3,114 | $1,636 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 23 | $2,207 | $1,573 | 71.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 11 | 11 | $1,362 | $569.70 | 41.8% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 62 | 1,650 | $27,687 | $21,331 | 77.0% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2021 | 68 | 933 | $11,389 | $7,664 | 67.3% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 24 | 1,248 | $5,490 | $4,217 | 76.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 30 | 37 | $4,950 | $3,652 | 73.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 20 | 20 | $3,471 | $2,706 | 78.0% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 22 | $4,065 | $2,542 | 62.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 22 | 22 | $2,553 | $1,775 | 69.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 22 | 25 | $2,363 | $1,656 | 70.1% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 13 | 13 | $249.21 | $249.21 | 100.0% |
| 95024 | Injection of allergenic extracts into skin for immediate reaction analysis | Office | 2021 | 11 | 32 | $295.40 | $236.04 | 79.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 13 | 13 | $230.75 | $230.75 | 100.0% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2020 | 12 | 340 | $5,321 | $4,257 | 80.0% |
| 95117 | Injection of incremental dosages of allergen, 2 or more injections | Office | 2020 | 56 | 156 | $1,794 | $1,432 | 79.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 14 | $1,630 | $823.04 | 50.5% |
About Dr. Amar Dixit, M.D
Dr. Amar Dixit, M.D is a Allergy & Immunology healthcare provider based in Beaumont, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1316381650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amar Dixit, M.D has received a total of $182,083 in payments from pharmaceutical and medical device companies, with $88,999 received in 2024. These payments were reported across 525 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($95,737).
As a Medicare-enrolled provider, Dixit has provided services to 533 Medicare beneficiaries, totaling 6,406 services with total Medicare billing of $75,865. Data is available for 3 years (2020–2022), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Other Specialties Pediatric Allergy/Immunology, Allergy & Immunology
- Location Beaumont, CA
- Active Since 04/17/2013
- Last Updated 08/28/2020
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1316381650
Products in Payments
- DUPIXENT (Biological) $73,599
- ORLADEYO (Drug) $34,163
- CINRYZE (Drug) $20,873
- Orladeyo (Drug) $9,876
- VTAMA (Drug) $2,009
- TAKHZYRO (Biological) $1,931
- NUCALA (Biological) $721.23
- RUCONEST (Biological) $553.88
- NO PRODUCT DISCUSSED (Drug) $407.00
- CUTAQUIG (Biological) $362.49
- ATOPIC DERMATITIS - DISEASE (Drug) $319.90
- DUPIXENT (Drug) $307.94
- CUVITRU (Biological) $288.28
- Haegarda (Biological) $259.01
- FASENRA (Drug) $253.35
- FASENRA (Biological) $160.55
- EUCRISA (Drug) $157.74
- ACTIMMUNE (Drug) $153.62
- Hizentra (Biological) $142.83
- OFEV (Drug) $124.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.